Home Nucleus Pharmaceuticals North America Influenza Drug Market to 2032

North America Influenza Drug Market to 2032

Overview

The North America Influenza Drug Market is expected to reach a 5.88 USD Billion by 2032 and is projected to grow at a CAGR of 10.32% from 2025 to 2032.

Revenue, 2024 (USD Billion)
3.15
Forecast, 2032 (USD Billion)
5.88
CAGR, 2024 - 2032
10.32%
Report Coverage
North America

North America Influenza Drug Market 2018-2032 USD Billion

North America Influenza Drug Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 3.15 USD Billion
  • Projected Market Size (2032): 5.88 USD Billion
  • CAGR (2025-2032): 10.32%

Key Findings of North America Influenza Drug Market

  • The North America Influenza Drug Market was valued at 3.15 USD Billion in 2024.
  • The North America Influenza Drug Market is likely to grow at a CAGR of 10.32% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Vaccines in Treatment Segment accounted for the largest share of the market with a revenue of 5.51 USD Billion
  • The fastest growing segment Oral in Route of Administration Segment grew Fastest with a CAGR of 11.02% during the forecast period from 2024 to 2032.

North America Influenza Drug Market Scope

North America Influenza Drug Market Segmentation & Scope
Type
  • Influenza C
  • Influenza B
  • Influenza A
Treatment
  • Drugs
  • Vaccines
Age
  • Adults
  • Pediatrics
End User
  • Homecare
  • Hospitals
Distribution Channel
  • Retail Sales
  • Direct Tender
Route of Administration
  • Intravenous
  • Intranasal
  • Intradermal
  • Intramuscular
  • Oral

North America Influenza Drug Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Billion
Market Value in 2024 3.15 USD Billion
Market Value in 2032 5.88 USD Billion
CAGR (2025-2032) 10.32%
Historic Data 2016-2023
Market Segments Covered Type,Treatment,Age,End User,Distribution Channel,Route of Administration

Regional Insights:

  • Leading Market (2024-2032): North America, leading in terms of revenue 3.15 USD Billion in 2024
    • Key Country: U.S., leading in terms of revenue with value of 1,779.64 USD Million in 2024.

Segments and Scope

  • North America Influenza Drug Market to 2032, By Type
    • Influenza A is the largest segment in North America Influenza Drug Market to 2032 with a revenue of 1.52 USD Billion in the year 2024.
    • Influenza A is the Fastest growing segment in North America Influenza Drug Market to 2032 with a Growth rate of 10.79 % in forecast period 2025-2032.
  • North America Influenza Drug Market to 2032, By Treatment
    • Vaccines is the largest segment in North America Influenza Drug Market to 2032 with a revenue of 5.51 USD Billion in the year 2024.
    • Vaccines is the Fastest growing segment in North America Influenza Drug Market to 2032 with a Growth rate of 10.35 % in forecast period 2025-2032.
  • North America Influenza Drug Market to 2032, By Age
    • Pediatrics is the largest segment in North America Influenza Drug Market to 2032 with a revenue of 1.62 USD Billion in the year 2024.
    • Pediatrics is the Fastest growing segment in North America Influenza Drug Market to 2032 with a Growth rate of 10.74 % in forecast period 2025-2032.
  • North America Influenza Drug Market to 2032, By End User
    • Hospitals is the largest segment in North America Influenza Drug Market to 2032 with a revenue of 2.29 USD Billion in the year 2024.
    • Hospitals is the Fastest growing segment in North America Influenza Drug Market to 2032 with a Growth rate of 10.48 % in forecast period 2025-2032.
  • North America Influenza Drug Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in North America Influenza Drug Market to 2032 with a revenue of 1.80 USD Billion in the year 2024.
    • Direct Tender is the Fastest growing segment in North America Influenza Drug Market to 2032 with a Growth rate of 10.63 % in forecast period 2025-2032.
  • North America Influenza Drug Market to 2032, By Route of Administration
    • Oral is the largest segment in North America Influenza Drug Market to 2032 with a revenue of 1.51 USD Billion in the year 2024.
    • Oral is the Fastest growing segment in North America Influenza Drug Market to 2032 with a Growth rate of 11.02 % in forecast period 2025-2032.

North America Influenza Drug Market Company Share Analysis

 
Company Name Company Share Analysis
Sanofi
AstraZeneca
GSK plc.
CSL
F. Hoffmann-La Roche Ltd.
North America Influenza Drug Market Company Share Analysis

North America Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Billion

North America Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Billion

North America Influenza Drug Market Company Profiling

North America Influenza Drug Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The North America Influenza Drug Market is segmented based on Segmentation Type,Treatment,Age,End User,Distribution Channel,Route of Administration.
North America Influenza Drug Market was valued at USD 3.15(Revenue in USD Billion) in 2022.
North America Influenza Drug Market is projected to grow at a CAGR of 10.32% during the forecast period of 2024 to 2032.
The Vaccines segment is expected to dominate the North America Influenza Drug Market, holding a largest market share of 5.51 USD Billion in 2024

North America Influenza Drug Market Scope

North America Influenza Drug Market Segmentation & Scope
Type
  • Influenza C
  • Influenza B
  • Influenza A
Treatment
  • Drugs
  • Vaccines
Age
  • Adults
  • Pediatrics
End User
  • Homecare
  • Hospitals
Distribution Channel
  • Retail Sales
  • Direct Tender
Route of Administration
  • Intravenous
  • Intranasal
  • Intradermal
  • Intramuscular
  • Oral
Frequently Asked Questions
The North America Influenza Drug Market is segmented based on Segmentation Type,Treatment,Age,End User,Distribution Channel,Route of Administration.
North America Influenza Drug Market was valued at USD 3.15(Revenue in USD Billion) in 2022.
North America Influenza Drug Market is projected to grow at a CAGR of 10.32% during the forecast period of 2024 to 2032.
The estimated market value of the North America Influenza Drug Market for final year is USD 5.88 (USD Billion).

North America Influenza Drug Market Company Profiling

North America Influenza Drug Market Company Profiling
Frequently Asked Questions
The North America Influenza Drug Market is segmented based on Segmentation Type,Treatment,Age,End User,Distribution Channel,Route of Administration.
North America Influenza Drug Market was valued at USD 3.15(Revenue in USD Billion) in 2022.
North America Influenza Drug Market is projected to grow at a CAGR of 10.32% during the forecast period of 2024 to 2032.
The estimated market value of the North America Influenza Drug Market for final year is USD 5.88 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES